Article Sidebar
Views Full article: 53
Effectiveness of bio-cellulose in Lyell syndrome treatment
Main Article Content
Abstract
The skin is the largest organ of the human body consisting of several layers possessing different properties and performing different physiological functions. The loss of skin integrity caused by a trauma or disease may provoke acute physiological and immune disorders that may even be fatal. Therefore, there are many benefits when choosing the right material, such as pain and patient discomfort reduction; reduce fluid loss through the wound; anti-infection; support of the epithelialization process, and reduces treatment costs.
In this report, we would like to introduce the effective treatment of Biocellulose biofilm through a severe Lyell syndrome patient.
Article Details
Keywords
Lyell, treatment
References
2. Khuwaja A., Shahab A., Hussain S. A. (2012) Acetaminophen-induced Steven Johnson syndrome-toxic epidermal necrolysis overlap. Journal of the Pakistan Medical Association, 62 (5), 524.
3. Downey A., Jackson C., Harun N., et al. (2012) Toxic epidermal necrolysis: a review of pathogenesis and management. Journal of the American Academy of Dermatology, 66 (6), 995-1003.
4. Gerull R., Nelle M., Schaible T. (2011) Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Critical care medicine, 39 (6), 1521-1532.
5. Zavala S., O’Mahony M., Joyce C., et al. (2018) How does SCORTEN score? Journal of burn care & research, 39 (4), 555-561.
6. Rajput R., Sagari S., Durgavanshi A., et al. (2015) Paracetamol induced Steven-Johnson syndrome: A rare case report. Contemporary clinical dentistry, 6 (Suppl 1), S278.
7. Mądry R., Strużyna J., Stachura-Kułach A., et al. (2011) Effectiveness of Suprathel® application in partial thickness burns, frostbites and Lyell syndrome treatment. Polski Przeglad Chirurgiczny, 83 (10), 541-548.
8. Budania R. J., Dakhale G. N., Sontakke S. D., et al. (2013) Fatal Stevens-Johnson syndrome induced by phenytoin: A case report. International Journal of Basic & Clinical Pharmacology, 2 (6), 843-846.